Golden State Wealth Management, LLC Lexicon Pharmaceuticals, Inc. Transaction History
Golden State Wealth Management, LLC
- $673 Billion
- Q1 2025
A detailed history of Golden State Wealth Management, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 3,700 shares of LXRX stock, worth $2,738. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,700
Previous 7,400
50.0%
Holding current value
$2,738
Previous $3,000
56733.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LXRX
# of Institutions
135Shares Held
196MCall Options Held
310KPut Options Held
77.3K-
Artal Group S.A. Luxembourg, N4136MShares$101 Million100.0% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$7.32 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.56MShares$7.07 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.21MShares$6.08 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA3.69MShares$2.73 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $140M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...